About
Technology
Issues
FAQ
Links
Official Page
Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.